UTHR : Analysis & Opinions

  1. Pipeline Progess at ArQule - Analyst Blog

    February 6, 2013
    ArQule, Inc. (ARQL) and partner Daiichi Sankyo recently announced that former has enrolled the first patient for the phase ...
  2. Pluristem Moves to New Facility - Analyst Blog

    January 31, 2013
    Pluristem Therapeutics, Inc. (PSTI) recently announced that it has taken possession of its new state-of-the-art facility ...
  3. Expedia and Other Big Movers on the Nasdaq on December 13, 2 ...

    December 13, 2012
    This morning has been rocky for the market. The Nasdaq is down 0.4%; the S&P 500 has declined 0.3%; and the Dow has decreased ...
  4. Regeneron Pharmaceuticals and More Big Movers in Healthcare on ...

    December 13, 2012
    The Nasdaq has decreased 0.4%, the S&P 500 has fallen 0.3% and the Dow is down 0.2% on a bad morning for the market. The ...
  5. Healthcare Stocks, Including BioMarin Pharmaceutical, Making ...

    November 5, 2012
    The Nasdaq has moved up 0.1%, the S&P 500 has declined 0.3% and the Dow has slipped 0.3% so far today. The healthcare sector ...
  6. Strong 3Q for United Therapeutics - Analyst Blog

    November 2, 2012
    United Therapeutics Corp. (UTHR) reported third-quarter earnings of $1.46 per share, well above the year-ago earnings of ...
  7. Facebook Inc. - Class Among the Nasdaq's Biggest Movers on October ...

    October 24, 2012
    The Nasdaq has remained steady, the S&P 500 is up 0.1% and the Dow has moved up 0.3% so far today. The recent surge in popularity ...
  8. Healthcare Stocks, Including Gilead, Making Big Moves on October ...

    October 24, 2012
    So far today, the Nasdaq remains relatively unchanged, the S&P 500 has risen 0.1% and the Dow has climbed 0.3%. The healthcare ...
  9. Arena Pharma Initiates PAH Study - Analyst Blog

    October 15, 2012
    Arena Pharmaceuticals, Inc. (ARNA) recently initiated a phase I multiple dose study with APD811, which is being developed ...
  10. Gilead Among Healthcare's Biggest Movers on October 2, 2012

    October 2, 2012
    So far today, the Nasdaq has climbed 0.4%, the S&P 500 is up 0.1% and the Dow is trading down 0.2%. The healthcare sector ...
  11. Baxter and Other Healthcare Stocks Making Big Moves on September ...

    September 26, 2012
    This morning's trading has marked a bad day for the market so far. The Nasdaq has slipped 1%; the S&P 500 has fallen 0.5%; ...
  12. Gilead and More Big Movers in Healthcare on September 17, 2012

    September 17, 2012
    The market is having a bad day so far: the Nasdaq has slipped 0.2%; the S&P 500 has declined 0.2%; and the Dow is trading ...
  13. Gilead Among Healthcare's Biggest Movers on September 14, 2012

    September 14, 2012
    The market has been doing well after the morning's trading. The Nasdaq has risen 1.1%; the S&P 500 has increased 0.6%; and ...
  14. Celgene and Other Big Movers In Healthcare on August 30, 2012

    August 30, 2012
    The market is currently down, with the Nasdaq slipping 0.9%, the S&P 500 down 0.7% and the Dow declining 0.7%. The healthcare ...
  15. 4 Heavily Shorted Stocks That Could Climb Higher

    January 3, 2012
    With the global equity markets still struggling, short-sellers have plenty of options. Here are four heavily shorted stocks ...
  16. LivePerson Looks To Have A Long Life

    October 14, 2011
    LivePerson's been around for over a decade. Only now is it coming alive. I'll look at why.
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center